LA Jolla Pharma (LJPC)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
06-2022 | 03-2022 | 12-2021 | 09-2021 | 06-2021 | |
Sales | 10,543 | 10,425 | 12,210 | 13,314 | 16,059 |
Cost of Goods | 1,697 | 2,170 | 2,130 | 2,872 | 2,156 |
Gross Profit | 8,846 | 8,255 | 10,080 | 10,442 | 13,903 |
Operating Expenses | 10,613 | 10,471 | 10,190 | 10,789 | 10,266 |
Operating Income | -1,070 | -2,046 | 20 | 525 | 3,793 |
Interest Expense | 2,372 | 2,402 | 2,448 | 2,729 | 2,672 |
Other Income | 5,917 | 4,451 | 6,197 | -25 | 2,612 |
Pre-tax Income | 2,475 | 3 | 3,769 | -2,229 | 3,733 |
Income Tax | 17 | 1 | N/A | 31 | 0 |
Net Income Continuous | 2,458 | 2 | 3,769 | -2,260 | 3,733 |
Net Income | $2,458 | $2 | $3,769 | $-2,260 | $3,733 |
EPS Basic Total Ops | 0.10 | 0.00 | 0.13 | -0.08 | 0.14 |
EPS Basic Continuous Ops | 0.10 | 0.00 | 0.14 | -0.08 | 0.14 |
EPS Diluted Total Ops | 0.08 | 0.00 | 0.13 | -0.08 | 0.11 |
EPS Diluted Continuous Ops | 0.08 | 0.00 | 0.13 | -0.08 | 0.11 |
EPS Diluted Before Non-Recurring Items | 0.08 | 0.00 | 0.12 | -0.08 | 0.11 |
EBITDA(a) | $-616 | $-1,590 | $484 | $993 | $4,279 |